The HSPB8 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population generated from the A-549 human lung epithelial carcinoma cell line, designed for loss-of-function studies of the HSPB8 gene. This polyclonal pool contains a heterogeneous collection of edited alleles resulting from CRISPR/Cas9-mediated disruption of the target gene, providing a robust model for investigating HSPB8-dependent cellular processes. The product format allows researchers to bypass single-cell cloning and directly assess population-level phenotypes, making it suitable for early-stage functional genomic screening and pathway dissection.
The host cell background is the A-549 cell line, originally established from explanted human lung adenocarcinoma tissue. A-549 cells are a widely utilized model of non-small cell lung cancer, exhibiting epithelial morphology and retaining key characteristics of lung adenocarcinoma, including expression of wild-type EGFR and KRAS mutations. Their well-characterized biology and responsiveness to chemotherapeutic agents render A-549 cells a mainstay for drug metabolism studies, oncogenic signaling research, and cancer cell biology investigations.
HSPB8 encodes a small heat shock protein that functions as a molecular chaperone crucial for protein quality control and cellular stress resistance. Mechanistically, HSPB8 collaborates with its co-chaperone BAG3 to recognize misfolded or aggregated proteins and deliver them to the autophagy-lysosomal pathway for degradation. This complex also interacts with Hsp70/Hsc70, the ubiquitin ligase CHIP/STUB1, and the adaptor protein p62/SQSTM1 to facilitate selective autophagy. Upstream, HSPB8 expression is transcriptionally regulated by heat shock factor 1 (HSF1) and FOXO transcription factors in response to proteasome inhibition, HDAC inhibitor treatment, and various cellular stresses, including heat shock and oxidative stress. Downstream, HSPB8 promotes autophagic flux and suppresses apoptosis signaling, thereby preventing toxic protein accumulation and maintaining proteostasis.
In the context of A-549 lung adenocarcinoma cells, HSPB8-mediated proteostasis may influence tumor cell survival under the stressful conditions of the tumor microenvironment, such as hypoxia, nutrient deprivation, and exposure to chemotherapeutic drugs. Ablation of HSPB8 in this model therefore enables interrogation of its role in autophagy-driven drug resistance, regulatory mechanisms controlling protein aggregation, and the interplay between chaperone networks and apoptotic cell death. This knockout tool is particularly relevant for dissecting the contribution of chaperone-assisted selective autophagy to lung cancer pathology.
Researchers can employ these polyclonal knockout cells to investigate HSPB8 function in lung cancer cell stress responses, autophagy-mediated protein clearance, and chemoresistance mechanisms. Typical assays include western blotting for HSPB8 and the autophagosome marker LC3-II, autophagy flux analyses using bafilomycin A1 to block lysosomal degradation, immunofluorescence staining for ubiquitinated protein aggregates, and cell viability measurements under proteotoxic stress induced by proteasome inhibitors or oxidative agents. Transcriptional responses can be quantified by RT-qPCR for HSPB8 and related stress genes. For additional technical details and ordering information, please contact Ascent Research.
